QCM
ABUS icon

Quantinno Capital Management’s Arbutus Biopharma ABUS Stock Holding History

Quantinno Capital Management’s Portfolio ABUS Stock Details ABUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$273K Buy
56,961
+8,246
+17% +$36.2K ﹤0.01% 3236
2026
Q1 		$219K Sell
48,715
-5,950
-11% -$26K ﹤0.01% 3176
2025
Q4 		$263K Buy
54,665
+18,769
+52% +$84.4K ﹤0.01% 2908
2025
Q3 		$163K Buy
+35,896
New +$132K ﹤0.01% 2813

Other funds holding ABUS

TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
WCM
Whitefort Capital Management New York $406M AUM 84.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Quantinno Capital Management's ABUS Position: Q2 2026 in Review

Quantinno Capital Management increased its Arbutus Biopharma (ABUS) stake by 17% in Q2 2026, buying an estimated $36.2K and bringing the position to 56,961 shares worth $273K. The position accounts for ﹤0.01% of the portfolio, ranked #3236.

Quantinno Capital Management first reported a position in ABUS in Q3 2025 and has held it in 4 quarters since. 176 funds tracked by Wall St. Rank hold ABUS as of Q2 2026.

  • Quantinno Capital Management held 56,961 shares of Arbutus Biopharma worth $273K as of Q2 2026.
  • Quantinno Capital Management bought 8,246 Arbutus Biopharma shares in Q2 2026, an estimated $36.2K.
  • Arbutus Biopharma made up ﹤0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #3236 holding.
  • Quantinno Capital Management first reported a position in Arbutus Biopharma in Q3 2025 and has held it in 4 quarters since.
  • 176 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.